Are you Dr. Anker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Burlington, VT 05401Phone+1 860-918-2399Fax+1 801-585-2666
Summary
- Dr. Christopher Anker, MD is a radiation oncologist in Burlington, Vermont. He is currently licensed to practice medicine in Vermont, New York, and Utah. He is affiliated with University of Vermont Medical Center and is an Assistant Professor at University of Utah School of Medicine.
Education & Training
- University of Utah HealthResidency, Radiation Oncology, 2006 - 2010
- SUNY Upstate Medical UniversityInternship, Internal Medicine, 2005 - 2006
- SUNY Upstate Medical UniversityClass of 2005
Certifications & Licensure
- NY State Medical License 2023 - 2025
- VT State Medical License 2013 - 2024
- UT State Medical License 2006 - 2014
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 106 citationsMelanoma, Version 2.2013 Featured Updates to the NCCN GuidelinesDaniel G. Coit, Robert H.I. Andtbacka, Christopher J. Anker, Christopher K. Bichakjian, William E. Carson
Journal of the National Comprehensive Cancer Network. 2013-04-01 - 103 citationsRadiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice GuidelineManisha Palta, Devon J. Godfrey, Karyn A. Goodman, Sarah E. Hoffe, Laura A. Dawson
Practical Radiation Oncology. 2019-09-01 - 149 citationsEffect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized ...Mohan Suntharalingam, Kathryn Winter, David H. Ilson, Adam P. Dicker, Lisa A. Kachnic
JAMA Oncology. 2017-11-01
Press Mentions
- Chromosomally Unstable Tumor Cells Specifically Require KIF18A for ProliferationFebruary 22nd, 2021